Cohance Lifesciences Strengthens ADC Strategy with Investments in NJ Bio and Aruka Bio MM Desk 7 September, 2026 Cohance Lifesciences Limited has announced two proposed transactions aimed at strengthening its antibody-drug conjugate (ADC) Read More
Umang Vohra Appointed Executive Chairman and Group CEO of Cohance Lifesciences MM Desk 5 May, 2026 Cohance Lifesciences Limited has announced the appointment of Umang Vohra as Executive Chairman, effective May Read More